242 related articles for article (PubMed ID: 24262631)
1. Bladder pain relief by HMGB1 neutralization and soluble thrombomodulin in mice with cyclophosphamide-induced cystitis.
Tanaka J; Yamaguchi K; Ishikura H; Tsubota M; Sekiguchi F; Seki Y; Tsujiuchi T; Murai A; Umemura T; Kawabata A
Neuropharmacology; 2014 Apr; 79():112-8. PubMed ID: 24262631
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human soluble thrombomodulin prevents peripheral HMGB1-dependent hyperalgesia in rats.
Tanaka J; Seki Y; Ishikura H; Tsubota M; Sekiguchi F; Yamaguchi K; Murai A; Umemura T; Kawabata A
Br J Pharmacol; 2013 Nov; 170(6):1233-41. PubMed ID: 24004409
[TBL] [Abstract][Full Text] [Related]
3. Involvement of high mobility group box 1 in the development and maintenance of chemotherapy-induced peripheral neuropathy in rats.
Nishida T; Tsubota M; Kawaishi Y; Yamanishi H; Kamitani N; Sekiguchi F; Ishikura H; Liu K; Nishibori M; Kawabata A
Toxicology; 2016 Jul; 365():48-58. PubMed ID: 27474498
[TBL] [Abstract][Full Text] [Related]
4. HMGB1 and its membrane receptors as therapeutic targets in an intravesical substance P-induced bladder pain syndrome mouse model.
Irie Y; Tsubota M; Maeda M; Hiramoto S; Sekiguchi F; Ishikura H; Wake H; Nishibori M; Kawabata A
J Pharmacol Sci; 2020 Jun; 143(2):112-116. PubMed ID: 32222337
[TBL] [Abstract][Full Text] [Related]
5. Macrophage-derived HMGB1 as a Pain Mediator in the Early Stage of Acute Pancreatitis in Mice: Targeting RAGE and CXCL12/CXCR4 Axis.
Irie Y; Tsubota M; Ishikura H; Sekiguchi F; Terada Y; Tsujiuchi T; Liu K; Nishibori M; Kawabata A
J Neuroimmune Pharmacol; 2017 Dec; 12(4):693-707. PubMed ID: 28755135
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the endogenous hydrogen sulfide/Ca(v) 3.2 T-type Ca2+ channel pathway in cystitis-related bladder pain in mice.
Matsunami M; Miki T; Nishiura K; Hayashi Y; Okawa Y; Nishikawa H; Sekiguchi F; Kubo L; Ozaki T; Tsujiuchi T; Kawabata A
Br J Pharmacol; 2012 Oct; 167(4):917-28. PubMed ID: 22646666
[TBL] [Abstract][Full Text] [Related]
7. Disulfide high mobility group box-1 causes bladder pain through bladder Toll-like receptor 4.
Ma F; Kouzoukas DE; Meyer-Siegler KL; Westlund KN; Hunt DE; Vera PL
BMC Physiol; 2017 May; 17(1):6. PubMed ID: 28545586
[TBL] [Abstract][Full Text] [Related]
8. Cystitis-Related Bladder Pain Involves ATP-Dependent HMGB1 Release from Macrophages and Its Downstream H
Hiramoto S; Tsubota M; Yamaguchi K; Okazaki K; Sakaegi A; Toriyama Y; Tanaka J; Sekiguchi F; Ishikura H; Wake H; Nishibori M; Nguyen HD; Okada T; Toyooka N; Kawabata A
Cells; 2020 Jul; 9(8):. PubMed ID: 32707767
[TBL] [Abstract][Full Text] [Related]
9. Polaprezinc attenuates cyclophosphamide-induced cystitis and related bladder pain in mice.
Murakami-Nakayama M; Tsubota M; Hiruma S; Sekiguchi F; Matsuyama K; Kimura T; Moriyama M; Kawabata A
J Pharmacol Sci; 2015 Feb; 127(2):223-8. PubMed ID: 25727961
[TBL] [Abstract][Full Text] [Related]
10. Role of Thrombin in Soluble Thrombomodulin-Induced Suppression of Peripheral HMGB1-Mediated Allodynia in Mice.
Tsujita R; Tsubota M; Hayashi Y; Saeki H; Sekiguchi F; Kawabata A
J Neuroimmune Pharmacol; 2018 Jun; 13(2):179-188. PubMed ID: 29196860
[TBL] [Abstract][Full Text] [Related]
11. Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1.
Kouzoukas DE; Ma F; Meyer-Siegler KL; Westlund KN; Hunt DE; Vera PL
PLoS One; 2016; 11(3):e0152055. PubMed ID: 27010488
[TBL] [Abstract][Full Text] [Related]
12. Effect of tramadol on pain-related behaviors and bladder overactivity in rodent cystitis models.
Oyama T; Homan T; Kyotani J; Oka M
Eur J Pharmacol; 2012 Feb; 676(1-3):75-80. PubMed ID: 22197002
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human soluble thrombomodulin ameliorates cerebral ischemic injury through a high-mobility group box 1 inhibitory mechanism without hemorrhagic complications in mice.
Nakamura Y; Nakano T; Irie K; Sano K; Tanaka J; Yamashita Y; Satho T; Matsuo K; Fujioka M; Ishikura H; Mishima K
J Neurol Sci; 2016 Mar; 362():278-82. PubMed ID: 26944163
[TBL] [Abstract][Full Text] [Related]
14. Evidence of a role for spinal HMGB1 in ischemic stress-induced mechanical allodynia in mice.
Matsuura W; Harada S; Liu K; Nishibori M; Tokuyama S
Brain Res; 2018 May; 1687():1-10. PubMed ID: 29476751
[TBL] [Abstract][Full Text] [Related]
15. Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants.
Tsubota M; Fukuda R; Hayashi Y; Miyazaki T; Ueda S; Yamashita R; Koike N; Sekiguchi F; Wake H; Wakatsuki S; Ujiie Y; Araki T; Nishibori M; Kawabata A
J Neuroinflammation; 2019 Oct; 16(1):199. PubMed ID: 31666085
[TBL] [Abstract][Full Text] [Related]
16. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the cystathionine-γ-lyase/Ca
Tsubota M; Okawa Y; Irie Y; Maeda M; Ozaki T; Sekiguchi F; Ishikura H; Kawabata A
Neuropharmacology; 2018 May; 133():254-263. PubMed ID: 29407215
[TBL] [Abstract][Full Text] [Related]
18. Urinary bladder sigma-1 receptors: A new target for cystitis treatment.
González-Cano R; Artacho-Cordón A; Romero L; Tejada MA; Nieto FR; Merlos M; Cañizares FJ; Cendán CM; Fernández-Segura E; Baeyens JM
Pharmacol Res; 2020 May; 155():104724. PubMed ID: 32105755
[TBL] [Abstract][Full Text] [Related]
19. Systemic involvement of high-mobility group box 1 protein and therapeutic effect of anti-high-mobility group box 1 protein antibody in a rat model of crush injury.
Shimazaki J; Matsumoto N; Ogura H; Muroya T; Kuwagata Y; Nakagawa J; Yamakawa K; Hosotsubo H; Imamura Y; Shimazu T
Shock; 2012 Jun; 37(6):634-8. PubMed ID: 22392147
[TBL] [Abstract][Full Text] [Related]
20. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
